Ryan Crandall - 28 Sep 2025 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
Chief Commercial Officer
Signature
/s/ Ryan Crandall
Issuer symbol
MRMD
Transactions as of
28 Sep 2025
Net transactions value
-$254
Form type
4
Filing time
29 Sep 2025, 17:30:56 UTC
Previous filing
16 Sep 2025
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Crandall Ryan Chief Commercial Officer 10 OCEANA WAY, 2ND FLOOR, NORWOOD /s/ Ryan Crandall 29 Sep 2025 0002062820

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +6,046 +0.83% $0.000000 733,713 28 Sep 2025 Direct F1
transaction MRMD Common stock Tax liability $254 -1,775 -0.24% $0.1430 731,938 28 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -6,046 -25% $0.000000 18,140 28 Sep 2025 Common Stock, par value $.001 per share 6,046 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3 These RSUs were granted on September 28, 2024; the remaining RSUs will vest in three equal installments on each of March 28, 2026, September 28, 2026 and March 28, 2027 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.